Detection of residual prostate cancer after external radiotherapy. Role of prostate specific antigen and transrectal ultrasonography Academic Article Article uri icon

Overview

MeSH Major

  • Databases, Factual
  • Information Storage and Retrieval
  • Medicine
  • Natural Language Processing
  • Specialization
  • Vocabulary, Controlled

abstract

  • The most clinically useful model for predicting histologically identifiable residual cancer was either a serum PSA value greater than 2 or a PSA value less than or equal to 2 and abnormal TRUS findings. The positive and negative predictive values of the model were 84% and 83%, respectively. The model predicted biopsy results correctly in 26 of 31 patients (84%). Transrectal ultrasonography is recommended as a diagnostic tool for patients whose PSA level ranges from a detectable level to less than or equal to 2 ng/mL.

publication date

  • January 1995

Research

keywords

  • Academic Article

Identity

Digital Object Identifier (DOI)

  • 10.1002/1097-0142(19950415)75:8<2153::AID-CNCR2820750819>3.0.CO;2-G

PubMed ID

  • 7535185

Additional Document Info

start page

  • 2153

end page

  • 8

volume

  • 75

number

  • 8